07.08.10
Genzyme and Hospira have entered a new supply agreement under which Hospira’s One 2 One Contract Manufacturing group will fill and package several of Genzyme’s biologics.
In May, the FDA finalized the terms of the consent decree regarding quality issues at Genzyme’s Allston, MA manufacturing plant, under which Genzyme paid an upfront disgorgement of past profits of $175 million. Genzyme is also required to move fill/finish operations out of the Allston plant for Cerezyme, Fabrazyme and Thyrogen sold within the U.S. by November 28, 2010, and by August 31, 2011 for products sold outside of the U.S.
The new agreement between Hospira One 2 One and Genzyme supplants prior agreements between the companies regarding the filling and packaging of drugs, including Cerezyme, Fabrazyme, Thyrogen and Myozyme. Hospira One 2 One will fill and finish manufacturing services for these medicines, as well as Lumizyme, Thymoglobulin, Campath, and certain products currently being developed by Genzyme. Multiple Hospira One 2 One facilities will be involved in the agreement.
Click here to learn more about Hospira One 2 One
In May, the FDA finalized the terms of the consent decree regarding quality issues at Genzyme’s Allston, MA manufacturing plant, under which Genzyme paid an upfront disgorgement of past profits of $175 million. Genzyme is also required to move fill/finish operations out of the Allston plant for Cerezyme, Fabrazyme and Thyrogen sold within the U.S. by November 28, 2010, and by August 31, 2011 for products sold outside of the U.S.
The new agreement between Hospira One 2 One and Genzyme supplants prior agreements between the companies regarding the filling and packaging of drugs, including Cerezyme, Fabrazyme, Thyrogen and Myozyme. Hospira One 2 One will fill and finish manufacturing services for these medicines, as well as Lumizyme, Thymoglobulin, Campath, and certain products currently being developed by Genzyme. Multiple Hospira One 2 One facilities will be involved in the agreement.
Click here to learn more about Hospira One 2 One